Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,734 total articles
Joseph W. LaPlume, Executive Vice President of Corporate Strategy & Development at Charles River Laboratories International Inc (NYSE: CRL), purchased 25 shares on March 3, 2026, for $174.54 each, a transaction valued at $4,363. The company recently reported fourth-quarter 2025 results that exceeded analyst expectations and disclosed plans to dives…
Catherine T. Doherty, Executive Vice President at Quest Diagnostics (DGX), completed two separate stock disposals on March 2 and March 3, 2026. One sale on March 3 involved 632 shares at $207.73 worth $131,285. A March 2 disposal of 648 shares at $204.86, totaling $132,749, was executed to cover tax obligations tied to vesting restricted share unit…
Verisign Executive Vice President, General Counsel and Secretary Thomas C. Indelicarto sold 498 shares of Verisign stock on March 3, 2026, across two trades that generated $115,426. The filing records his post-sale holdings and recent dividend-equivalent restricted stock units; the company reported mixed fourth-quarter 2025 results and trades at a …
NeuroPace Inc.'s Chief Medical Officer, Martha Morrell, executed a pre-arranged sale of 25,000 shares on December 15, 2025, realizing $399,250. Subsequent withholding of 1,340 vested restricted shares occurred on March 3, 2026 to cover tax obligations. The company reported fourth-quarter 2025 results that beat analyst forecasts on both EPS and reve…
Amy Parison, senior vice president and chief financial officer of Editas Medicine, sold 474 shares of the company’s common stock on March 3, 2026, under a pre-arranged automatic sales plan established in 2022 to meet tax obligations arising from restricted stock units that vested on March 2, 2026. The trade, reported on a Form 4 filing, totaled $95…
Pedro J. Lopez-Baldrich, Chief Legal Officer of SharkNinja, sold 24,099 ordinary shares on March 3, 2026, in multiple transactions under a Rule 10b-5 trading plan. The disposals totaled $2,775,261 at prices between $113.64 and $116.37. SharkNinja is valued at $16.2 billion and recent quarterly results showed adjusted sales growth of 17.6%, with adj…
Caroline Cochran, co-founder and chief operating officer of Oklo Inc. (OKLO), sold Class A common shares on March 2, 2026, in transactions totaling $12,658,097. The sales were carried out under a Rule 10b5-1 trading plan adopted March 31, 2025. The moves come amid significant corporate developments for Oklo, including a binding agreement with Meta …
Editas Medicine Executive Vice President and Chief Scientific Officer Linda Burkly sold 749 shares on March 3, 2026, under a pre-established automatic sales instruction plan to satisfy tax withholding tied to restricted stock unit vesting. The disposal generated roughly $1,512. The sale was not a discretionary trade, and Burkly retains a direct sta…
Morningstar CFO Michael Holt bought 1,000 shares of Morningstar common stock on March 4, 2026, at $186.59 per share, bringing his direct holdings to 9,480 shares. The company completed its $365 million acquisition of the Center for Research in Security Prices (CRSP), will fold CRSP Market Indexes into its index family, raised its quarterly dividend…
Graphic Packaging Holding Co's President and CEO, Robbert Rietbroek, purchased 44,278 shares on March 4, 2026, spending roughly $501,098. The trade occurred as the stock traded close to its 52-week low and after the company reported fourth-quarter 2025 results that included an EPS shortfall alongside a modest revenue beat. An analyst reduced the pr…
Alignment Healthcare Chief Human Resources Officer Andreas P. Wagner sold 21,118 shares of the company's common stock on March 4, 2026, generating roughly $393,250. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted Nov. 21, 2025. The company additionally disclosed a secondary offering led by an affiliate of Gener…
Director Lee Sang Young purchased 2,092 shares of PCB Bancorp common stock in early March 2026, spending $47,524 in open-market transactions. The purchases, executed on March 3 and March 4, increased Lee's beneficial holdings to 1,592,961 shares. The transactions coincide with PCB Bancorp's recent dividend increase to $0.22 per share and the compan…
Akamai director Ranganathan Madhu sold 3,131 shares on March 4, 2026, for $319,362. The transaction leaves him with 9,160 shares. The stock trades near $102.98 and has returned 31% over six months. Separately, Akamai reported Q4 results that beat revenue and earnings estimates, saw 44% year-over-year growth in its Cloud and Infrastructure Services …
Michael C. Bucella, a director at Terawulf Inc. (NASDAQ: WULF), purchased 3,171 shares of common stock on March 4, 2026 for $15.78 per share, a $50,038 investment that brings his direct holdings to 270,129 shares. The transaction was reported on a Form 4 filing with the Securities and Exchange Commission. The purchase comes amid heightened share-pr…
Crinetics Pharmaceuticals Chief Financial Officer Tobin Schilke sold 6,713 shares on March 3, 2026, for $266,304 to meet tax obligations tied to RSU vesting. The sale, executed under a pre-arranged Rule 10b5-1 plan, leaves Schilke with 78,121 shares. The company recently beat Q4 2025 EPS and revenue estimates, while at least one analyst trimmed a p…
Michele Farmer, Chief Accounting Officer at Pacific Biosciences of California, sold 2,979 shares on March 3, 2026, to satisfy tax withholding obligations tied to RSU vesting. The trade totaled $4,510 at a weighted average price of $1.514. Separately, Pacific Biosciences reported fourth-quarter 2025 results that beat analyst expectations on both EPS…
Suzan Kereere, PayPal’s President of Global Markets, sold 13,515 shares of PayPal on March 3, 2026, for a total of $621,984 under a Rule 10b5-1 trading plan adopted in March 2025. The trades occurred as PayPal shares trade near $46.75 and have fallen 31% over six months, while market commentary and unsolicited interest from potential buyers have in…
International Seaways Senior Vice President William F. Nugent sold 9,583 shares on March 2, 2026, for roughly $728,327 as the stock traded near a 52-week high. The company reported robust fourth-quarter 2025 results and declared a record quarterly dividend, while at least one analyst raised its price target to $80.
Cricut CEO Ashish Arora disposed of 73,458 Class A shares across March 2 and 3, 2026, generating proceeds of $313,853 under a Rule 10b5-1 program. The sales leave Arora with just under 3.73 million shares. The stock trades at $4.52 and carries a $957 million market cap. Cricut posted a slight beat on Q4 2025 EPS and revenue but showed year-over-yea…
Meta Platforms COO Javier Olivan disposed of 1,555 shares of the company's Class A common stock on March 2, 2026, in five transactions executed under a pre-arranged Rule 10b5-1 plan. The trades totaled about $990,861 at $637.21 per share. Following the sales Olivan directly holds 16,113 shares. Meta's stock has since risen to $667.73, with the comp…
A consortium of investors classified as 10% owners of US Energy Corp (USEG) disposed of 709,449 common shares on March 2 and 3, 2026, generating roughly $907,086. The sellers include Joshua Lane Batchelor, Sage Road Capital, Banner Oil & Gas, Woodford Petroleum, and Benjamin Andrew Stamets. Separately, US Energy Corp sold 6,525,843 shares to Roth P…
Douglas M. Pasquale, a director at Dine Brands Global, Inc. (DIN), acquired 3,000 shares of common stock in multiple purchases between March 2 and March 3, 2026, for total consideration of $89,309. The purchases bring his total holdings to 23,022.313 shares. The trades occur amid active management buybacks, a recent mixed earnings report for fiscal…
Q2 Holdings Chief Executive Officer Matthew P. Flake sold 118,511 shares of common stock on March 3 and March 4, 2026 to satisfy tax obligations tied to the vesting of performance-based restricted stock units. The transactions, disclosed in an SEC Form 4 filing, generated roughly $5.89 million. The move comes amid mixed Q4 results for Q2 Holdings a…
Q2 Holdings Inc. Chief Financial Officer Jonathan Price completed an issuer-directed sale of 39,836 shares on March 3 and March 4, 2026, generating roughly $1.98 million to satisfy tax withholding tied to restricted stock unit vesting. The transactions follow the final vesting of performance-based RSUs and occur amid mixed analyst responses to the …
Q2 Holdings' Chief Operating Officer, Himagiri K Mukkamala, sold 1,793 shares on March 4, 2026, in a company-mandated transaction to satisfy tax withholding tied to restricted stock unit vesting. The sale, executed at a weighted average price between $49.75 and $50.05, raised roughly $89,201. The disclosure comes as Q2 reported a fourth-quarter EPS…
